21 CFR 369.3
§ 369.3 Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C).
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 369.3, § 369.3 Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C), United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86769
- Permanent ID
ys:prov:86769@1- SHA-256
a55b21963f35ab59828f0a9b8d7c407017a37e0b172b3e801b158fea16076ac1
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Drugs exempted from prescription-dispensing requirements under section 503(b)(1)(C) of the act are subject to the labeling requirements prescribed in § 310.201(a) of this chapter. Although, for convenience, warning and caution statements for a number of the drugs named in § 310.201 of this chapter (cross-referenced in the text of this part) are included in subpart B of this part, the inclusion of such drugs in §§ 369.20 or 369.21 in no way affects the requirements for compliance with § 310.201(a) of this chapter, or the provisions of an effective application pursuant to section 505(b) of the act.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.